Ligand Pharmaceuticals
LGND
#4146
Rank
NZ$3.69 B
Marketcap
$191.68
Share price
-4.82%
Change (1 day)
63.94%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.53

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.75. In 2022 the company made an earnings per share (EPS) of -$3.47 a decrease over its 2021 EPS that were of $6.07.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.53-173%
2022-$3.47-157.23%
2021$6.07-2571.43%
2020-$0.25-100.46%
2019$53.68353.48%
2018$11.841025%
2017$1.05-700%
2016-$0.18-100.87%
2015$20.271859.32%
2014$1.035.36%
2013$0.988.0704505322479E+18%
2012$0.0000000000-100%
2011$0.86-194.23%
2010-$0.91548.38%
2009-$0.14-98.7%
2008-$10.84-136.52%
2007$29.67-787.8%
2006-$4.31-14.58%
2005-$5.05-21.31%
2004-$6.42-55.15%
2003-$14.3181.33%
2002-$7.892.74%
2001-$7.68-45.93%
2000-$14.20-14.56%
1999-$16.63-45.52%
1998-$30.51-3.97%
1997-$31.78132.31%
1996-$13.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.81 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.63-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.14 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.19 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.26 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.52 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.96 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.98 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.70 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA